Markets

AptarGroup To Acquire PULMOTREE, A Munich, Germany-based Life Science Company Specializing In Pulmonary Drug Delivery Systems For Targeted Delivery To The Lungs; Terms Not Disclosed

Oct 26, 2026 · 05:01 PM ET· updated 44m ago

Acquisition is expected to accelerate development and commercialization of Kolibri™ and expand Aptar Pharma’s respiratory drug delivery platformAptar Pharma, a global leader in drug delivery, dosing, protection

Why It Matters

AptarGroup bought a company that makes special inhalers for lung medicine. This helps Aptar add new tools to its medicine delivery business and grow faster.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

ATR127.07

+0.52 (+0.41%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.